LatestChemotherapy Alters 'Darwinian Battleground' in Our Bodies
Health

International Trial Supports New Strategy Against Metastatic Prostate Cancer

Diario Salud Redacción
International Trial Supports New Strategy Against Metastatic Prostate Cancer
Cancer
Summary

A phase III international clinical trial published in The Lancet demonstrates that adding Lutetium-177 PSMA (Lu-PSMA), a targeted radioligand therapy, to standard hormone treatment reduces the risk of disease progression or death by 28% in patients with metastatic prostate cancer. The PSMAddition study provides significant evidence for this combined therapeutic approach in treating advanced prostate cancer. This breakthrough offers new hope for patients with metastatic disease, potentially extending survival and improving treatment outcomes. The findings may change clinical practice guidelines and expand treatment options for Puerto Rican men battling this aggressive form of cancer.

Originally published on

DiarioSalud.do

By Diario Salud Redacción

Read full article(opens in new tab)

Fetched: September 11, 2026 at 10:01 AM

Related News

More news you might be interested in

View all
Chemotherapy Alters 'Darwinian Battleground' in Our Bodies
Health
Cancer

Chemotherapy Alters 'Darwinian Battleground' in Our Bodies

New research reveals that cancer treatments like chemotherapy and radiation therapy can give certain cells with specific genetic mutations a growth advantage in healthy tissue. This phenomenon creates a competitive environment where these genetically altered cells may proliferate after treatment ends. Scientists are studying this 'Darwinian battleground' to better understand how cancer treatments affect healthy cells and whether this adaptation could lead to secondary cancers or other complications. Understanding these cellular changes is crucial for improving cancer therapy strategies and protecting patients from long-term treatment side effects. Researchers emphasize the need for further investigation to develop safer, more targeted cancer treatments.

15 hours ago
Medical Xpress
Where 9/11 Responders Live May Influence Frailty, PTSD and Depression Decades Later
Health
AnxietyDepression

Where 9/11 Responders Live May Influence Frailty, PTSD and Depression Decades Later

Twenty-five years after the September 11 attacks, researchers at Mount Sinai's Icahn School of Medicine discovered that environmental conditions where World Trade Center responders live significantly influence their long-term physical and mental health outcomes. The study reveals that geographic and socioeconomic factors play a crucial role in the development of frailty, post-traumatic stress disorder (PTSD), and depression among survivors. These findings suggest that healthcare interventions and support services should be tailored to responders' living environments. Understanding this connection helps identify vulnerable populations who may require targeted mental health and geriatric care.

15 hours ago
Medical Xpress
Cardiovascular-Kidney-Metabolic Disease Risk Factors Detectable in Children as Young as Eight
Health
High CholesterolDiabetes

Cardiovascular-Kidney-Metabolic Disease Risk Factors Detectable in Children as Young as Eight

Researchers from UTHealth Houston have discovered that risk factors for cardiovascular-kidney-metabolic disease—a cluster condition encompassing heart disease, kidney disease, diabetes, and obesity—can be identified in children as young as eight years old. This groundbreaking finding suggests that early detection and intervention strategies could be implemented during childhood to prevent or delay the onset of these serious conditions. The identification of these risk factors at such a young age offers a critical opportunity for lifestyle modifications and preventive care before complications develop. Understanding which children are at highest risk could help healthcare providers implement targeted interventions during these formative years. This research underscores the importance of comprehensive metabolic and cardiovascular screening in pediatric populations.

15 hours ago
Medical Xpress
Researchers Uncover Mechanism Behind Dangerous Blood-Clotting Disorder
Health
Heart Disease

Researchers Uncover Mechanism Behind Dangerous Blood-Clotting Disorder

McMaster University researchers have identified why certain patients develop dangerous blood clots after exposure to common blood thinners, offering potential prevention strategies. This breakthrough addresses a serious complication that can occur in patients requiring anticoagulation therapy. Understanding the underlying mechanism could lead to improved treatment protocols and safer medication use. The findings are particularly important for patients with heart disease, stroke prevention, and those undergoing surgery who rely on blood thinners for protection.

15 hours ago
Medical Xpress